Gyno-Pevaryl Combipack (Econazole Nitrate)

Gyno-Pevaryl Combipack is indicated for the treatment of vulvovaginal candidiasis, a common yeast infection of the vagina and surrounding tissues.

• Treatment of acute vulvovaginal candidiasis caused by Candida species.
• Management of recurrent yeast infections when prescribed by a clinician.
• Relief of associated symptoms such as itching, burning, and abnormal discharge.
• Use as part of a comprehensive antifungal regimen for resistant infections.
• Application in patients who require a vaginally administered imidazole antifungal.
• Suitable for women of reproductive age, pending medical evaluation of pregnancy status.
• Can be used when other topical antifungals are contraindicated or not tolerated.

The safety profile of Gyno-Pevaryl Combipack reflects the typical adverse reactions observed with vaginal imidazole antifungals, most of which are mild, localized, and transient.

Common

• Mild vaginal irritation or burning sensation.
• Local itching or redness.
• Unpleasant odor or discharge unrelated to infection.
• Headache or mild gastrointestinal discomfort.
• Temporary spotting or light bleeding.
• Mild abdominal cramps.
• Transient increase in vaginal discharge.
• Mild skin irritation at the applicator tip.

Serious

• Severe allergic reaction such as rash, swelling, or difficulty breathing.
• Persistent or worsening vaginal symptoms despite treatment.
• Signs of secondary bacterial infection, including fever or foul-smelling discharge.
• Liver enzyme abnormalities detected in laboratory tests.
• Rare cases of Stevens-Johnson syndrome reported with systemic absorption.

When considering Gyno-Pevaryl Combipack, clinicians and patients should observe several precautionary measures to ensure safe and effective use.

• Confirm diagnosis of vulvovaginal candidiasis before initiating therapy.
• Assess pregnancy status; use only if benefits outweigh potential risks.
• Avoid use in women with known hypersensitivity to econazole or other imidazoles.
• Do not insert the applicator beyond the vaginal introitus to prevent injury.
• Refrain from sexual intercourse or tampon use for at least 24 hours after application.
• Seek medical attention if symptoms persist beyond the recommended treatment course.

Gyno-Pevaryl Combipack may interact with other medicines or substances applied vaginally; reviewing concomitant therapies helps minimize adverse effects.

Avoid

• Concurrent use of other topical antifungal agents, which can increase local irritation.
• Simultaneous administration of vaginal spermicides containing nonoxynol‑9, as they may reduce antifungal efficacy.
• Use with intravaginal hormonal preparations (e.g., estrogen creams) without medical advice.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) because of potential additive inhibition of fungal enzymes.
• Oral contraceptives, although no direct interaction is established, monitor for menstrual changes.
• Anticoagulant therapy, as rare systemic absorption could theoretically affect bleeding risk.